Skip to main content
Fig. 4 | BMC Biotechnology

Fig. 4

From: Antifungal efficacy of Citrusfusion mediated silver nanoparticles in Candida species

Fig. 4

Antibacterial potential of CitAgNPs in Candida strains: (a) Candida albicans ATCC 10231, (b) Candida albicans, (c) Candida tropicalis, (d) Candida metapsilosis Whereas the wells denote A. 25 μL of silver nitrate solution, B. CitAgNPs 12.5 μg/mL, C. CitAgNPs 25 μg/mL, D. CitAgNPs 50 μg/mL, E. CitAgNPs 100 μg/mL, F. 25 μL of fluconazole (1 mg/mL)

Back to article page